Viatris (VTRS) Total Debt Growth (1y) (2020 - 2026)
Viatris (VTRS) Total Debt Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.78 Bn | 87.91 Bn | - | -11.90% |
| 2 | Teva Pharmaceutical Industries | 35.95 Bn | 32.20 Bn | 1.97 Bn | -0.14% |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn | 37.52% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -2.81% |
| 5 | United Therapeutics | 23.01 Bn | 20.85 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.41 Bn | 18.61 Bn | 1.16 Bn | -9.53% |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.45 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.66 Bn | 12.23 Bn | 785.00 Mn | -13.33% |
| 10 | Vireo Growth | 10.51 Bn | 10.36 Bn | 59.30 Mn | 217.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.53% |
| Dec 31, 2025 | 2.67% |
| Sep 30, 2025 | -9.62% |
| Jun 30, 2025 | -11.78% |
| Mar 31, 2025 | -11.79% |
| Dec 31, 2024 | -22.53% |
| Sep 30, 2024 | -6.44% |
| Jun 30, 2024 | -5.01% |
| Mar 31, 2024 | -1.66% |
| Dec 31, 2023 | -5.97% |
| Sep 30, 2023 | -12.33% |
| Jun 30, 2023 | -13.54% |
| Mar 31, 2023 | -5.89% |
| Dec 31, 2022 | -10.67% |
| Sep 30, 2022 | -10.38% |
| Jun 30, 2022 | -10.10% |
| Mar 31, 2022 | -12.29% |
| Dec 31, 2021 | -8.30% |
| Sep 30, 2021 | 88.43% |
| Jun 30, 2021 | 95.14% |